Toremifene – 60mg (30 tabs)

Toremifene 60 mg is an oral medication containing 60 mg of toremifene citrate per tablet. Toremifene is classified as a Selective Estrogen Receptor Modulator (SERM) and is used in the management of certain hormone-sensitive conditions under medical supervision.

Active Ingredient

Toremifene Citrate selectively binds to estrogen receptors. In breast tissue, it primarily acts as an estrogen receptor antagonist, reducing the stimulatory effects of estrogen on certain cancer cells.

Composition

Each tablet typically contains:

• Toremifene Citrate – equivalent to 60 mg toremifene

• Pharmaceutical excipients such as fillers, binders, and coating agents

Inactive ingredients vary depending on the manufacturer.

Mechanism of Action

Toremifene competes with estrogen for binding to estrogen receptors in target tissues. By blocking estrogen activity in breast tissue, it helps slow or inhibit the growth of estrogen receptor–positive (ER+) breast cancer cells. In other tissues, it may exert partial estrogen-like effects.

Medical Uses

Toremifene is commonly prescribed for the treatment of metastatic or advanced estrogen receptor–positive breast cancer in postmenopausal women. Treatment decisions and duration are determined by a qualified healthcare professional.

Pharmacological Characteristics

Toremifene is absorbed after oral administration and metabolized primarily in the liver. It has a relatively long elimination half-life, supporting once-daily dosing in most clinical settings.